Multiple amino acid substitutions in lanosterol 14alpha-demethylase contribute to azole resistance in Candida albicans.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Microbiology

• Publication date

  1999-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1099/00221287-145-10-2715PMID 10537193
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fluconazole Resistance Associated with Drug Efflux and Increased Transcription of a Drug Transporter Gene, PDH1, inCandida glabrata

  1998cited by this paper
• Cytochromes P450 in fungi.

  1998cited by this paper
• Distinct Patterns of Gene Expression Associated with Development of Fluconazole Resistance in Serial Candida albicansIsolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis

  1998cited by this paper
• Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance

  1998cited by this paper
• Diethylcarbamazine-related antimicrobial activity in Mycobacterium tuberculosis-infected blood.

  1998cited by this paper
• The ABC family of multidrug transporters in microorganisms.

  1998cited by this paper
• Mechanism of Fluconazole Resistance inCandida krusei

  1998cited by this paper
• Amino Acid Substitutions in the Cytochrome P-450 Lanosterol 14α-Demethylase (CYP51A1) from Azole-Resistant Candida albicans Clinical Isolates Contribute to Resistance to Azole Antifungal Agents

  1998cited by this paper
• In Vitro Activities of Terbinafine against Cutaneous Isolates of Candida albicans and Other Pathogenic Yeasts

  1998cited by this paper
• Review Article Cytochromes P450 in fungi

  1998influential reference
• Identification and Expression of Multidrug Transporters Responsible for Fluconazole Resistance in Candida dubliniensis

  1998cited by this paper
• In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.

  1998cited by this paper
• Experimental models in antifungal chemotherapy

  1998cited by this paper
• Molecular analysis of cyp51 from fluconazole-resistant Candida albicans strains.

  1997cited by this paper
• The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans

  1997influential reference
• Differential inhibition of fungal amd mammalian squalene epoxidases by the benzylamine SDZ SBA 586 in comparison with the allylamine terbinafine.

  1997cited by this paper
• Resistance to fluconazole and cross‐resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol Δ5,6‐desaturation

  1997cited by this paper
• The Mutation T315A in Candida albicans Sterol 14α-Demethylase Causes Reduced Enzyme Activity and Fluconazole Resistance through Reduced Affinity*

  1997cited by this paper
• Fluconazole tolerance in clinical isolates of Cryptococcus neoformans

  1997cited by this paper
• AP1-mediated Multidrug Resistance in Saccharomyces cerevisiae Requires FLR1 Encoding a Transporter of the Major Facilitator Superfamily*

  1997cited by this paper
• Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus

  1997cited by this paper
• Azole resistance in Candida.

  1997cited by this paper
• Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.

  1997cited by this paper
• Cloning and expression of squalene epoxidase from the pathogenic yeast Candida albicans.

  1997cited by this paper
• Protein Quality—A Determinant of the Intracellular Fate of Membrane-Bound Cytochromes P450 in Yeast

  1997cited by this paper
• Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance

  1996cited by this paper
• Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance

  1996cited by this paper
• Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors

  1996cited by this paper
• Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.

  1996cited by this paper
• Quality control guidelines for National Committee for Clinical Laboratory Standards--recommended broth macrodilution testing of ketoconazole and itraconazole

  1996cited by this paper
• The mechanism of the acyl-carbon bond cleavage reaction catalyzed by recombinant sterol 14 alpha-demethylase of Candida albicans (other names are: lanosterol 14 alpha-demethylase, P-45014DM, and CYP51).

  1996cited by this paper
• Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome

  1996cited by this paper
• Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents

  1996cited by this paper
• The Mechanism of the Acyl-Carbon Bond Cleavage Reaction Catalyzed by Recombinant Sterol 14α-Demethylase of Candida albicans (Other Names Are: Lanosterol 14α-Demethylase, P-45014DM, and CYP51) (*)

  1996cited by this paper
• Altered P450 activity associated with direct selection for fungal azole resistance

  1995cited by this paper
• Resistance of Candida species to fluconazole

  1995cited by this paper
• Resistant P45051A1 activity in azole antifungal tolerant Cryptococcus neoformans from AIDS patients

  1995cited by this paper
• Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals

  1995cited by this paper
• Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata

  1995cited by this paper
• Multidrug resistance in Candida albicans: disruption of the BENr gene

  1995cited by this paper
• Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters

  1995cited by this paper
• The CUG codon is decoded in vivo as serine and not leucine in Candida albicans.

  1995cited by this paper
• in Saccharomyces cerevisiae

  1995cited by this paper
• Origin of differences in susceptibility of Candida krusei to azole antifungal agents

  1995cited by this paper
• Modeling cytochrome P450 14 alpha demethylase (Candida albicans) from P450cam.

  1994cited by this paper
• Cloning and characterization of a yeast cytochrome b5-encoding gene which suppresses ketoconazole hypersensitivity in a NADPH-P-450 reductase-deficient strain.

  1994cited by this paper
• Molecular mechanisms of drug resistance in fungi.

  1994cited by this paper
• CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

  1994influential reference
• High prevalence of antifungal resistance in Candida spp. from patients with AIDS.

  1994cited by this paper
• Modeling cytochrome P450 14α demethylase (Candida albicans) from P450cam

  1994cited by this paper
• Resistance to imidazoles and triazoles in Saccharomyces cerevisiae as a new dominant marker.

  1993cited by this paper
• A model system for studying membrane biogenesis. Overexpression of cytochrome b5 in yeast results in marked proliferation of the intracellular membrane.

  1993cited by this paper
• Molecular genetic analysis of azole antifungal mode of action.

  1993cited by this paper
• Probing the membrane topology of Candida tropicalis cytochrome P450.

  1993cited by this paper
• Characterization of an azole-resistant Candida glabrata isolate

  1992cited by this paper
• High-efficiency transformation of yeast by electroporation.

  1991cited by this paper
• DNA of Saccharomyces cerevisiae.

  1991cited by this paper
• Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14 alpha-sterol demethylase purified from Candida albicans.

  1990cited by this paper
• Mutation in cytochrome P-450-dependent 14 alpha-demethylase results in decreased affinity for azole antifungals.

  1990cited by this paper
• Purification and properties of cytochrome P-450-dependent 14 alpha-sterol demethylase from Candida albicans.

  1989cited by this paper
• Nucleotide sequence of cytochrome P450 L1A1 (lanosterol 14 alpha-demethylase) from Candida albicans.

  1989cited by this paper
• Deformylation of 32-oxo-24,25-dihydrolanosterol by the purified cytochrome P-45014DM (lanosterol 14 alpha-demethylase) from yeast evidence confirming the intermediate step of lanosterol 14 alpha-demethylation.

  1989cited by this paper
• Disruption of the Saccharomyces cerevisiae gene for NADPH-cytochrome P450 reductase causes increased sensitivity to ketoconazole.

  1989cited by this paper
• Nucleotide sequence of cytochrome P450 LIAI (lanosterol 14α-demethylase) from Candida albicans

  1989cited by this paper
• Primary Structure of the Cytochrome P450 Lanosterol 14α-Demethylase Gene from Candida tropicalis

  1988cited by this paper
• A single amino acid substitution converts cytochrome P450(14DM) to an inactive form, cytochrome P450SG1: complete primary structures deduced from cloned DNAS.

  1988cited by this paper
• Squalene epoxidase as the target of antifungal allylamines

  1987cited by this paper
• High-resolution crystal structure of cytochrome P450cam.

  1987influential reference
• Isolation of a cytochrome P-450 structural gene from Saccharomyces cerevisiae.

  1986cited by this paper
• Specific inhibition of fungal sterol biosynthesis by SF 86-327, a new allylamine antimycotic agent

  1985cited by this paper
• Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albicans

  1984cited by this paper
• Azole resistance in Candida albicans.

  1984cited by this paper

• Machine learning identifies novel signatures of antifungal drug resistance in Saccharomycotina yeasts

  2025cites this paper
• Candida albicans: a historical overview of investigations into an important human pathogen.

  2025cites this paper
• Multiple resistance of Colletotrichum truncatum from soybean to QoI and MBC fungicides in Brazil

  2024cites this paper
• Pan‐azole‐resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11

  2024cites this paper
• Investigating role of positively selected genes and mutation sites of ERG11 in drug resistance of Candida albicans

  2024cites this paper
• Isolation and identification of Wickerhamiella tropicalis from blood culture by MALDI-MS

  2024cites this paper
• Antifungal drug resistance in Candida: a special emphasis on amphotericin B

  2024cites this paper
• Insights into the role of sphingolipids in antifungal drug resistance

  2024cites this paper
• Molecular Cloning, Heterologous Expression, Purification, and Evaluation of Protein–Ligand Interactions of CYP51 of Candida krusei Azole-Resistant Fungal Strain

  2023cites this paper
• Spectrum and functional properties of ERG11 gene mutations in fluconazole-resistant Candida albicans strains isolated from HIV-infected patients

  2023cites this paper
• Multiple resistance of Colletotrichum truncatum from soybean to QoI and MBC fungicides in Brazil

  2022cites this paper
• Structural Insights into the Azole Resistance of the Candida albicans Darlington Strain Using Saccharomyces cerevisiae Lanosterol 14α-Demethylase as a Surrogate

  2021cites this paper
• Large-scale genome mining allows identification of neutral polymorphisms and novel resistance mutations in genes involved in Candida albicans resistance to azoles and echinocandins.

  2020cites this paper
• Novel Resistance Mutations in Genes Involved in Candida albicans Resistance

  2020cites this paper
• A comprehensive overview of the medicinal chemistry of antifungal drugs: perspectives and promise.

  2020cites this paper
• Unraveling the importance of molecules of natural origin in antifungal drug development through targeting ergosterol biosynthesis pathway

  2019cites this paper
• The Impact of Gene Dosage and Heterozygosity on the Diploid Pathobiont Candida albicans

  2019cites this paper
• Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing

  2019cites this paper
• A point mutation in the 14  -sterol demethylase gene cyp51A contributes to the resistance to itraconazole of Aspergillus fumigatus.

  2019cites this paper
• Can Saccharomyces cerevisiae keep up as a model system in fungal azole susceptibility research?

  2019cites this paper
• Detection of azole resistance and ERG 11 point mutations in Candida albicans isolates from tertiary hospitals in the Philippines Moron LS

  2018cites this paper
• In silico analysis of cytochrome P450 monooxygenases in chronic granulomatous infectious fungus Sporothrix schenckii: Special focus on CYP51.

  2018cites this paper
• A Transcriptomics Approach To Unveiling the Mechanisms of In Vitro Evolution towards Fluconazole Resistance of a Candida glabrata Clinical Isolate

  2018cites this paper
• Selection Pressure Pathways and Mechanisms of Resistance to the Demethylation Inhibitor-Difenoconazole in Penicillium expansum

  2018cites this paper
• Mutations in Hotspot Regions of ERG11 Gene in Fluconazole Resistant Isolates of Candida albicans in Guilan Province, Northern Iran

  2017cites this paper
• Studying cross-talk between different transcriptional pathways controlling azole resistance in Candida albicans

  2017cites this paper
• Antimicrobial Drug Resistance

  2017cites this paper
• Sensitivity of Colletotrichum Species, Including C. fioriniae and C. nymphaeae, from Peach to Demethylation Inhibitor Fungicides.

  2016cites this paper
• The amino acid substitution N136Y in Candida albicans sterol 14alpha-demethylase is involved in fluconazole resistance.

  2016cites this paper
• In vitro evaluation of antifungal effects of nanoliposomal fl uconazole against fl uconazole susceptible and resistant Candida species isolated from patients

  2016cites this paper
• The development of fluconazole resistance in Candida albicans – an example of microevolution of a fungal pathogen

  2016cites this paper
• Mechanisms of Resistance to Antifungal Agents

  2015cites this paper
• Multidrug- and Cross-Resistant Candida: the Looming Threat

  2015cites this paper
• Update on Antifungal Drug Resistance

  2015cites this paper
• A combination approach to treating fungal infections

  2015cites this paper
• Amphiphilic Tobramycin Analogues as Antibacterial and Antifungal Agents

  2015cites this paper
• Determining the Mechanisms of Resistance to Drug Combinations and their Fitness Effects in Candida albicans

  2014cites this paper
• Structural basis for heterogeneous phenotype of ERG11 dependent Azole resistance in C.albicans clinical isolates

  2014influential citation
• Two missense mutations, E123Q and K151E, identified in the ERG11 allele of an azole-resistant isolate of Candida kefyr recovered from a stem cell transplant patient for acute myeloid leukemia

  2014cites this paper
• Candiduria among HIV- Infected Patients Attending a Tertiary Hospital in Benin City

  2014cites this paper
• Genome dynamics and virulence in the human pathogen Candida glabrata

  2014cites this paper
• Genetic diversity and antifungal susceptibility profiles in causative agents of sporotrichosis

  2014cites this paper
• Phenotypic and molecular genetic profiles of fluconazole and voriconazole sensitive versus resistant candida spp

  2014cites this paper
• Contribution of Clinically Derived Mutations in ERG11 to Azole Resistance in Candida albicans

  2014cites this paper
• Mechanisms of Drug Resistance in Fungi and Their Significance in Biofilms

  2014cites this paper
• Determining the Mode of Action of Ibomycin: A Novel Antifungal Compound

  2014cites this paper
• Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China.

  2013cites this paper
• Genetic and Genomic Architecture of the Evolution of Resistance to Antifungal Drug Combinations

  2013cites this paper
• Nucleotide substitutions in the Candida albicans ERG11 gene of azole-susceptible and azole-resistant clinical isolates.

  2013cites this paper
• Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans.

  2013cites this paper
• In Vitro Fluconazole Susceptibility of 1,903 Clinical Isolates of Candida albicans and the Identification of ERG11 Mutations

  2013cites this paper
• Perfil de suscetibilidade in vitro e caracterização molecular de leveduras do gênero Candida isoladas de pacientes com vulvovaginite

  2013cites this paper
• The identification of Candida species isolated from clinical specimens of immunocompromised patients with PCR and determination of antifungal resistance genes with RFLP and sequencing analysis

  2012cites this paper
• Adaptations in the wall proteome of the clinical fungus Candida albicans in response to infection-related environmental conditions

  2012cites this paper
• Characterization of the Chromosome 4 Genes That Affect Fluconazole-Induced Disomy Formation in Cryptococcus neoformans

  2012cites this paper
• Identificação e análise de mutações no gene ERG11 de isolados de Candida susceptíveis e resistentes ao fluconazol

  2011influential citation
• Caracterização do gene ERG11 envolvido na resistência de Cryptococcus neoformans e Cryptococcus gatti as drogas azólicas e identificação de novos alvos a partir de produtos naturais

  2011cites this paper
• Possible Inhibitory Molecular Mechanism of Farnesol on the Development of Fluconazole Resistance in Candida albicans Biofilm

  2011cites this paper
• Resistance to Antifungal Drugs

  2011cites this paper
• Diagnosis of Antifungal Drug Resistance Mechanisms in Fungal Pathogens: Transcriptional Gene Regulation

  2011cites this paper
• Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.

  2010cites this paper
• Identification and characterisation of four azole-resistant erg3 mutants of 2

  2010cites this paper
• Evaluation of the V404I and V509M amino acid substitutions of ERG11 gene in Candida albicans isolates by pyrosequencing

  2010cites this paper
• Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans

  2009cites this paper
• Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing

  2009cites this paper
• Fungal Drug Resistance: Azoles

  2009cites this paper
• Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation.

  2009cites this paper
• Sterol 24-C-methyltransferase: an enzymatic target for the disruption of ergosterol biosynthesis and homeostasis in Cryptococcus neoformans.

  2009cites this paper
• Reliability of the Vitek 2 Yeast Susceptibility Test for Detection of In Vitro Resistance to Fluconazole and Voriconazole in Clinical Isolates of Candida albicans and Candida glabrata

  2009cites this paper
• Aspergillus as a Human Pathogen: an Evolutionary Perspective

  2008cites this paper
• The Cytochrome P450 Lanosterol 14 (cid:2) -Demethylase Gene Is a Demethylation Inhibitor Fungicide Resistance Determinant in Monilinia fructicola Field Isolates from Georgia (cid:1) †

  2007cites this paper
• The Cytochrome P450 Lanosterol 14α-Demethylase Gene Is a Demethylation Inhibitor Fungicide Resistance Determinant in Monilinia fructicola Field Isolates from Georgia

  2007cites this paper
• A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A Alterations

  2007cites this paper
• Identification of Y118 amino acid residue in Candida albicans sterol 14alpha-demethylase associated with the enzyme activity and selective antifungal activity of azole analogues.

  2007cites this paper
• New resistance mechanisms to azole drugs in Aspergillus fumigatus and emergence of antifungal drugs-resistant A. fumigatus atypical strains.

  2006cites this paper
• Multidrug resistance in yeast Candida.

  2005cites this paper
• Inactivation of Sterol Δ5,6-Desaturase Attenuates Virulence in Candida albicans

  2005cites this paper
• Amino Acid Substitution in Trichophyton rubrum Squalene Epoxidase Associated with Resistance to Terbinafine

  2005cites this paper
• The Diversity and Importance of Microbial Cytochromes P450

  2005cites this paper
• Single amino acid exchanges in FAD-binding domains of squalene epoxidase of Saccharomyces cerevisiae lead to either loss of functionality or terbinafine sensitivity.

  2005cites this paper
• Inactivation of Sterol (cid:2) 5,6 -Desaturase Attenuates Virulence in Candida albicans

  2005cites this paper
• Inactivation of sterol Delta5,6-desaturase attenuates virulence in Candida albicans.

  2005cites this paper
• In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.

  2005cites this paper
• Azole susceptibility and resistance in Candida dubliniensis.

  2005cites this paper
• An update on antifungal targets and mechanisms of resistance in Candida albicans.

  2005cites this paper
• A Point Mutation in the 14α-Sterol Demethylase Gene cyp51A Contributes to Itraconazole Resistance in Aspergillus fumigatus

  2004cites this paper
• Drug resistance genes and trailing growth in Candida albicans isolates.

  2004cites this paper
• Biochemical characterization of terbinafine-resistant Trichophyton rubrum isolates.

  2004cites this paper
• CYP51 from Trypanosoma brucei is obtusifoliol-specific.

  2004cites this paper
• A Point Mutation in the 14α-Sterol Demethylase Gene cyp51A Contributes to Itraconazole Resistance in Aspergillus fumigatus

  2003cites this paper
• Saccharomyces cerevisiae Resistance in Molecular Mechanism of Terbinafine

  2003cites this paper
• Virus-induced silencing of sterol biosynthetic genes: identification of a Nicotiana tabacum L. obtusifoliol-14alpha-demethylase (CYP51) by genetic manipulation of the sterol biosynthetic pathway in Nicotiana benthamiana L.

  2003cites this paper
• Changes in susceptibility to posaconazole in clinical isolates of Candida albicans.

  2003cites this paper
• Molecular Mechanism of Terbinafine Resistance in Saccharomyces cerevisiae

  2003cites this paper
• The biodiversity of microbial cytochromes P450.

  2003cites this paper
• Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast.

  2003cites this paper
• Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.

  2002cites this paper
• The genetic basis of fluconazole resistance development in Candida albicans.

  2002cites this paper
• Molecular basis of resistance to azole antifungals.

  2002cites this paper
• Drug resistance in yeasts--an emerging scenario.

  2002cites this paper